# US 2008/0187926 A1 · Detection of Small Nucleic Acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0187926 A1
- Document ID: US20080187926A1
- Status: Published application
- Kind: A1
- Application number: 11/929,878
- Filed: 2007-10-30
- Published: 2008-08-07
- Earliest claimed: 2002-12-18
- Assignees: Third Wave Technologies, Inc.
- Inventors: James E. Dahlberg; Hatim T. Allawi; Victor Lyamichev; Bruce P. Neri; Marilyn C. Olson-Munoz; LuAnne Chehak; Sarah M. Olson
- Web page: https://patentgrep.com/patent/US20080187926A1

## CPC

- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- Y10T 436/145555: Hetero-N
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention relates to compositions and methods for the detection and characterization of interfering RNAs such as micro RNAs (miRNAs) and small interfering RNAs (siRNAs) and other short nucleic acid molecules. More particularly, the present invention relates to improved methods for the detection and quantitation of interfering RNA expression. The present invention further provides for the detection of variants and types of miRNAs and siRNAs.

## Claims

### Claim 1

A method, comprising:
a) hybridizing an interfering RNA target to at least one nucleic acid that contains sequence not complementary to said interfering RNA target to generate a detection structure; and
b) detecting said detection structure.

### Claim 2 (depends on 1)

The method of claim 1, wherein said interfering RNA target is an miRNA.

### Claim 3 (depends on 1)

The method of claim 1, wherein said interfering RNA target is an siRNA.

### Claim 4 (depends on 3)

The method of claim 3, wherein said siRNA is double stranded.

### Claim 5 (depends on 1)

The method of claim 1, wherein said detection structure comprises an invasive cleavage structure.

### Claim 6 (depends on 2)

The method of claim 2, wherein said detection structure comprises first and second oligonucleotides configured to form an invasive cleavage structure in combination with said miRNA.

### Claim 7 (depends on 2)

The method of claim 2, wherein said detection structure comprises a first oligonucleotide configured to form an invasive cleavage structure in combination with said miRNA.

### Claim 8 (depends on 6)

The method of claim 6, wherein said first oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 3′ portion is configured to hybridize to said target sequence, and wherein said 5′ portion is configured to not hybridize to said target sequence.

### Claim 9 (depends on 6)

The method of claim 6, wherein said second oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 5′ portion is configured to hybridize to said target sequence, and wherein said 3′ portion is configured to not hybridize to said target sequence.

### Claim 10 (depends on 1)

The method of claim 1, wherein said detecting comprises use of an invasive cleavage assay.

### Claim 11 (depends on 1)

The method of claim 1, wherein said detection structure comprises a circular oligonucleotide hybridized to said miRNA to generate a circular detection structure.

### Claim 12 (depends on 11)

The method of claim 11, wherein said detecting comprises use of a rolling circle replication assay.

### Claim 13 (depends on 1)

The method of claim 1, wherein said detecting comprises use of a detection assay selected from the group consisting of sequencing assays, polymerase chain reaction assays, hybridization assays, hybridization assays employing a probe complementary to a mutation, microarray assays, bead array assays, primer extension assays, enzyme mismatch cleavage assays, branched hybridization assays, NASBA assays, molecular beacon assays, cycling probe assays, ligase chain reaction assays, invasive cleavage structure assays, ARMS assays, and sandwich hybridization assays.

### Claim 14 (depends on 1)

The method of claim 1, wherein said detecting is carried out in cell lysates.

### Claim 15 (depends on 1)

The method of claim 1, wherein a plurality of different miRNAs are detected.

### Claim 16 (depends on 15)

The method of claim 15, wherein said plurality of miRNAs comprise a first miRNA and a second miRNA that is said first miRNA having a polymorphism.

### Claim 17 (depends on 1)

The method of claim 1, further comprising detecting a second nucleic acid target.

### Claim 18 (depends on 17)

The method of claim 17, wherein said second nucleic acid target is RNA.

### Claim 19 (depends on 18)

The method of claim 18, wherein said second nucleic acid target is selected from the group consisting of U6 and GAPDH.

### Claim 20 (depends on 2)

The method of claim 2, wherein said miRNA is selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR125b, miR-1d, and miR124a.

### Claim 21

A kit comprising a nucleic acid configured for forming a detection structure when hybridized to an interfering RNA target sequence, wherein the nucleic acid comprises sequence that is not complementary to said interfering RNA target sequence.

### Claim 22 (depends on 21)

The kit of claim 21, wherein said detection structure comprises an invasive cleavage structure.

### Claim 23 (depends on 22)

The kit of claim 22, wherein said first oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 3′ portion is configured to hybridize to said target sequence, and wherein said 5′ portion is configured to not hybridize to said target sequence.

### Claim 24 (depends on 22)

The kit of claim 22, wherein said second oligonucleotide comprises a 5′ portion and a 3′ portion, wherein said 5′ portion is configured to hybridize to said target sequence, and wherein said 3′ portion is configured to not hybridize to said target sequence.

### Claim 25 (depends on 21)

The kit of claim 21, wherein said detection structure comprises a circular oligonucleotide hybridized to said miRNA to generate a circular detection structure.

### Claim 26 (depends on 25)

The kit of claim 25, wherein said detection structure is a detection structure for a rolling circle replication assay.

### Claim 27 (depends on 21)

The kit of claim 21, wherein said interfering RNA target is an miRNA.

### Claim 28 (depends on 21)

The kit of claim 21, wherein said interfering RNA target is an siRNA.

### Claim 29 (depends on 27)

The kit of claim 27, wherein said miRNAs are selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR-1b, miR-124a, and miR125b.

### Claim 30 (depends on 21)

The kit of claim 21, wherein the kit is configured to detect an miRNA target and at least one other RNA target.

### Claim 31 (depends on 21)

The kit of claim 21, wherein the kit is configured to detect said interfering RNA target sequence in a cell lysate.
